The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Genentech; Pharmacyclics
A phase I study combining bendamustine with rituximab, etoposide and carboplatin (TREC) in patients with aggressive relapsed or refractory lymphoma.
 
L. Elizabeth Budde
Research Funding - Cell Medica (Inst); Gilead Sciences (Inst); Seagen (Inst)
 
Daniel B. Martin
No Relationships to Disclose
 
Mary Philip
No Relationships to Disclose
 
Andrei R. Shustov
Honoraria - Celgene
Consulting or Advisory Role - Celgene; Spectrum Pharmaceuticals
Research Funding - Amgen; Celgene; Gilead Sciences; Millennium; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Celgene; Spectrum Pharmaceuticals
 
Theodore Gooley
No Relationships to Disclose
 
Tara L Chen
No Relationships to Disclose
 
Edward N. Libby
No Relationships to Disclose
 
Eric Y. Chen
No Relationships to Disclose
 
Kiarash Kojouri
No Relationships to Disclose
 
Alan Langerak
Employment - Walgreens (I)
 
Jennifer E Roden
No Relationships to Disclose
 
Britt E Kammerer
No Relationships to Disclose
 
Nancy L Knudsen
No Relationships to Disclose
 
Stephen Douglas Smith
No Relationships to Disclose
 
Oliver W. Press
Stock and Other Ownership Interests - Emergent Biosolutions; PhaseRx
Consulting or Advisory Role - Adaptive Biotechnologies; Algeta ASA; BIND Biosciences; Roche
Research Funding - Genentech (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Algeta ASA; Roche
 
Ajay K. Gopal
Honoraria - Millennium; Seagen
Consulting or Advisory Role - Gilead Sciences; Janssen Biotech; Pfizer; Seagen
Speakers' Bureau - Millennium; Seagen
Research Funding - Abbott Laboratories (Inst); Biogen (Inst); Bristol-Myers Squibb/Medarex (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst)